Ver­tex gets NDA go­ing for CF triple com­bo; Dis­arm woos rare dis­ease ex­pert Alvin Shih as CEO

Ver­tex’s has of­fi­cial­ly set sail with its lat­est cys­tic fi­bro­sis triple com­bo, fil­ing an NDA to the FDA. Armed with a break­through ther­a­py …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.